Ho et al., Seminars in Oncology, vol. 24, 2, pp. 187-220, 1997.* |
Gilden et al. (GMHC Treat Issues, vol. 10, 3, pp. 1-5), 1996.* |
Stull et al. Pharmaceutical Research, vol. 12, 4, p. 476, col. 2, last paragraph, 1995.* |
Reynolds, Margaret R., Generalized Vaccinia, Symposium, pp. 5-6, 1960. |
Kuckku, Morris E., Herpetic Diseases, Symposium, pp. 7-13, 1960. |
Schaeffer, Oden A., Influenza, Symposium, pp. 15-21, 1960. |
Seydel, Frank, Epidemic, Asian Influenza, Symposium, pp. 23-24, 1960. |
Cooke, Stanford B., Upper Respiratory Viral Manifestations, Clinical Symposium on Viral Diseases Demonstrating the Anti-viral Biotic Properties of the Drug Reticulose (Symposium), Sep., 1960, Miami Beach, Florida, pp. 25-32. |
Medoff, Lawrence R., Infectious Mononucleosis, Symposium, pp. 33-37, 1960. |
Anderson, Robert H., Encephalitis, Symposium, pp. 39-52, 1960. |
Plucinski, Stanisloff J., Suspected Viral Varieties, Symposium, pp. 53-59, 1960. |
Kosaka, K. and Shimada, Y., Infectious Hepatitis, Symposium, pp. 61-74, 1960. |
Anderson, Robert H. and Thompson, Ralph M., Treatment of Viral Syndrome with a Lipoprotein-Nucleic Acid Compound (Reticulose), A Report of Five Cases, Virginia Medical Monthly, 84: 347-353, 1957. |
Reynolds, Margaret R., Generalized Vaccinia Successfully Treated With Lipoprotein-Nucleic Acid Complex (Reticulose), Archives of Pediatrics, 77:421-422, 1960. |
Wegryn, Stanley P., Marks, Robert A. and Baugh, John R., Herpes Gestationis, A Report of 2 Cases, American Journal of Obstetrics and Gynecology, 79:812-814, 1960. |
Catterall, R.A., Lumpur, Kuala, A New Treatment of Herpes Zoster, Vaccinia And Chicken Pox, J. Roy. Coll. Gen. Practit., 1970, 19, 182. |
Chinnici, Angelo A., Reticulose in Treatment Aids patients, Personal Communication to William Bregman, Jul. 6, 1992. |
Cott, Rafael A., Summary of 11 Cases of Viral Infections Treated with Reticulose, Private Communication with Advance Viral Research Corp., 1989. |
Cohen, Matthew, The Efficacy of a Peptide-Nucleic Acid Solution (Reticulose) for the Treatment of Hepatitis A and Hepatitis B—a Preliminary Controlled Human Clinical Trial, J. Roy. Soc. Health, Dec., 1992, 266-270. |
Mundschenk, David D., In Vitro Antiviral Activity of Reticulose vs Influenaz A, Personal Communication with William Bregman, May 1, 1990. |
Resnick, Lionel, Anti-HIV in Vitro Activity of Two Samples of Peptide-nucleic Acid Solution, Personal Communication with Dr. Bernard Friedland, Dec. 22, 1989. |
Friedland, Bernard, In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human Immunodeficiency Virus and Influenza A Virus, J. Roy. Soc. Health, Oct. 1991, 170-171. |
Brazier, Anne D., Method for in Vitro Antiviral Evaluation Human Immunodeficiency Virus (HIV), Personal Communication with Dr. Bernard Friedland, Oct. 4, 1989. |
Behbehani, Abbas M., Haberman Sol and Race, George J, The Effect of Reticulose on Viral Infections of Experimental Animals, Southern Medical Journal, Feb., 1962, 185-188. |
Treatment of Viral Diseases with A Lipo-protein Nucleic Acid Complex (Reticulose)—A Clinical Study, Scientific Exhibit: Virginia State Medical Society Meeting, Washington D.C., Nov., 1957. |
Kempe, Henry C., Fulginiti, Vincent A., and Vincent, Leone St., Failure to Demonstrate Antiviral Activity of Reticulose, Diseases of Children, vol. 103, No. 5, 655-657, 1962. |
Sanders, Murray, Controlled Animal Studies with Reticulose Illustrating the Interference of Lipoprotein-Nucleic Acid Complex in the Experimental Animal Infected with Human Pathogenic Viral Entities, Southern Medical Association Scientific Exhibit, Dallas, Texas, Nov., 1961. |
XP-001042169 “Reticulose Anti-HIV Trial Results”, vol. 9, No. 12 Dec. 1996. |
XP-002914304 Treatment of Viral Syndromes with a Lipo-Protein-Nucleic Acid Compound (Reticulose), vol. 84, Jul. 1957. |
XP-001042170 “Reticulose Enters Trials for Genital Warts; Shows Anti-HIV Activity”, vol. 9, No. 6, Jun. 1996. |
XP-002912075 “Peptide Nucleic Acids Stimulate Gamma Interferon and Inhibit the Replication of the Human Immunodeficiency Virus”, vol. 44, No. 6, Aug. 1996. |
Danner, S.A. et al., “A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, and Inhibitor of HIV-1 Protease”, vol. 333, No. 23 Dec. 1995. |
Geleziunas, R. et al., “Effect of 3′-Azido-3′-Deoxythymidine on Human Immunodeficiency Virus Type 1 Replication in Human Fetal Brain Macrophages”, vol. 37, No. 6, Jun. 1993. |
Friedland, Bernard, “In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human Immunodeficiency Virus and Influenza A Virus”, Joy Roy. Soc. Health, Oct. 1991, pp. 170-171. |